A new study at Montreal Heart Institute in Canada indicates that a new antioxidant drug shows benefits in the prevention and treatment of diabetes. Preliminary results on the drug, succinobucol, have been presented at medical meetings, but report say that more studies on cardiovascular risks needed.
Succinobucol is a chemical relative of probucol, a cholesterol-lowering drug […]
continue reading from " New Antioxidant Drug Shows Promise Against Diabetes "
